---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-014676"
form_type: "8-K"
ticker: "XAIR"
cik: "0001641631"
company_name: "Beyond Air, Inc."
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T07:58:59.896705+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Beyond Air CEO Steve Lisi resigns; Robert Goodman appointed CEO effective March 27, 2026

## Summary
- Steve Lisi resigned as CEO and director, effective March 27, 2026; no disagreement with the Company.
- Robert Goodman, previously Chief Commercial Officer and director, appointed CEO effective March 27, 2026.
- Lisi receives $650,000 severance over 12 months, 12 months of COBRA premiums, and accelerated vesting of all unvested equity.
- Goodman has 25+ years in healthcare sales leadership; prior roles include BioTelemetry, Philips, Cardiocore, Thermo Fisher, and Pfizer.

## SEC filing metadata
- accession: 0001493152-26-014676
- form_type: 8-K
- ticker: XAIR
- cik: 0001641631
- company_name: Beyond Air, Inc.
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641631/000149315226014676/0001493152-26-014676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641631/000149315226014676/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-014676
- JSON: https://secwatch.observer/filing/0001493152-26-014676.json
- Plain text: https://secwatch.observer/filing/0001493152-26-014676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.